Literature DB >> 16111761

GPCR modulation by RAMPs.

Debbie L Hay1, David R Poyner, Patrick M Sexton.   

Abstract

Our conceptual understanding of the molecular architecture of G-protein coupled receptors (GPCRs) has transformed over the last decade. Once considered as largely independent functional units (aside from their interaction with the G-protein itself), it is now clear that a single GPCR is but part of a multifaceted signaling complex, each component providing an additional layer of sophistication. Receptor activity-modifying proteins (RAMPs) provide a notable example of proteins that interact with GPCRs to modify their function. They act as pharmacological switches, modifying GPCR pharmacology for a particular subset of receptors. However, there is accumulating evidence that these ubiquitous proteins have a broader role, regulating signaling and receptor trafficking. This article aims to provide the reader with a comprehensive appraisal of RAMP literature and perhaps some insight into the impact that their discovery has had on those who study GPCRs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16111761     DOI: 10.1016/j.pharmthera.2005.06.015

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  73 in total

1.  The third extracellular loop of the human calcitonin receptor-like receptor is crucial for the activation of adrenomedullin signalling.

Authors:  Kenji Kuwasako; Debbie L Hay; Sayaka Nagata; Tomomi Hikosaka; Kazuo Kitamura; Johji Kato
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

2.  Characterization of the structure of RAMP1 by mutagenesis and molecular modeling.

Authors:  John Simms; Debbie L Hay; Mark Wheatley; David R Poyner
Journal:  Biophys J       Date:  2006-04-21       Impact factor: 4.033

Review 3.  Biased signalling and allosteric machines: new vistas and challenges for drug discovery.

Authors:  Terry P Kenakin
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

4.  Secretin family (Class B) G protein-coupled receptors - from molecular to clinical perspectives.

Authors:  David R Poyner; Debbie L Hay
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 5.  Orphan G protein-coupled receptors (GPCRs): biological functions and potential drug targets.

Authors:  Xiao-long Tang; Ying Wang; Da-li Li; Jian Luo; Ming-yao Liu
Journal:  Acta Pharmacol Sin       Date:  2012-02-27       Impact factor: 6.150

Review 6.  Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery.

Authors:  Terry Kenakin; Laurence J Miller
Journal:  Pharmacol Rev       Date:  2010-04-14       Impact factor: 25.468

7.  Regulation of G protein-coupled receptor signaling: specific dominant-negative effects of melanocortin 2 receptor accessory protein 2.

Authors:  Julien A Sebag; Patricia M Hinkle
Journal:  Sci Signal       Date:  2010-04-06       Impact factor: 8.192

Review 8.  Allostery at G protein-coupled receptor homo- and heteromers: uncharted pharmacological landscapes.

Authors:  Nicola J Smith; Graeme Milligan
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

Review 9.  Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors.

Authors:  Craig W Lindsley; Kyle A Emmitte; Corey R Hopkins; Thomas M Bridges; Karen J Gregory; Colleen M Niswender; P Jeffrey Conn
Journal:  Chem Rev       Date:  2016-02-16       Impact factor: 60.622

10.  Reduced maternal expression of adrenomedullin disrupts fertility, placentation, and fetal growth in mice.

Authors:  Manyu Li; Della Yee; Terry R Magnuson; Oliver Smithies; Kathleen M Caron
Journal:  J Clin Invest       Date:  2006-09-14       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.